Femasys Inc. - Common Stock — Cash Flow (NASDAQ:FEMY)

Financials

Cash from operating activities -7.93 M-10.73 M-11.28 M-19.44 M-18.69 M -18.07 M Cash from investing activities -306.87 K-407.48 K-143.92 K-847.76 K-630.1 K -612.63 K Cash from financing activities 29.7 M-681.64 K20.18 M2.03 M25.14 M 20.25 M Free cash flow -7.93 M-10.73 M-11.28 M-19.44 M-19.32 M -18.68 M

News

Femasys begins enrollment in pivotal trial for FemBloc device

Lake Street initiates Femasys stock coverage with buy rating

Femasys receives CPT code approval for infertility treatment

Femasys expands European presence with Swiss distribution deal

Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule

Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment

Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232

Pharmacyte Biotech CEO Silverman buys $80k in shares

Femasys receives FDA clearance for FemVue Controlled diagnostic device

PharmaCyte Biotech stock soars after successful Femasys stake sale

PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million

Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential